Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
Mitra A; Fisher C; Foster CS; Jameson C; Barbachanno Y; Bartlett J; Bancroft E; Doherty R; Kote-Jarai Z; Peock S; Easton D; Eeles R; British Journal Of Cancer, 2008, vol. 98, issue 2, p 502, ISSN 00070920. ISBN 00070920.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef